Psoriasis

Descriptive text is not available for this imageBASICS

DESCRIPTION

  • A chronic relapsing skin disease most often characterized by thick white scales over erythematous plaques often involving elbows, knees, and scalp (i.e., psoriasis vulgaris); in children, psoriasis may present with less scaling and more erythema than in adults; may also present as diaper rash
  • Other variants include the following:
    • Guttate psoriasis—drop-like plaques on the chest, back, and limbs; often follows group A streptococcal infections in children (i.e., strep throat)
    • Inverse psoriasis—lesions in flexures, also called intertriginous
    • Erythrodermic psoriasis—a severe variant with widespread erythematous skin involvement often accompanied by fever; can be life-threatening
    • Pustular psoriasis—generalized or localized, often affecting palms and soles; potentially lethal
    • Psoriatic arthritis—joint pain can precede skin involvement.

EPIDEMIOLOGY

  • Involves both genders equally
  • Onset of psoriasis is bimodal, commonly presenting in the 3rd decade with a smaller second peak of onset in the 6th decade; however, it can present at any age. Mean age of onset in children is 8.1 years.
  • Earlier onset is associated with more severe disease.
  • Psoriasis is universal in occurrence, but prevalence varies in different populations. The average prevalence in the United States is ~1–3%.

ETIOLOGY

The pathogenesis is unknown, possibly an immune-mediated inflammatory disease. Genetic factors are important. Well-defined trigger factors include the following:

  • Trauma—psoriasis can develop in areas of trauma (i.e., isomorphic response, sometimes called the Koebner phenomenon).
  • Infections (e.g., upper respiratory infections, Streptococcus pyogenes, HIV)
  • Stress
  • Winter in colder climates in Northern Hemisphere
  • Some drugs (i.e., systemic corticosteroids, lithium, nonsteroidal anti-inflammatory drugs (NSAIDs), and antimalarials)

RISK FACTORS

Genetics

  • Although psoriasis has a strong genetic influence, mode of transmission is not defined. It is likely multifactorial with more than one gene involved and is modified by environmental influence.
  • One-third of patients with psoriasis report a relative with the disease. In family studies, 8.1% of children develop psoriasis when one parent is affected. When both parents have psoriasis, the affected percentage increases to 41%.
  • In twin studies, 65% of monozygotic twins are concordant for the disease, whereas only 30% of dizygotic twins are concordant.

PATHOPHYSIOLOGY

  • Plaque-type psoriasis is characterized by a thickened parakeratotic epidermis with an absent granular layer above dermal papillae containing dilated tortuous capillaries.
  • Collections of polymorphonuclear leukocytes extend from the dermal papillae into the epidermidis stratum corneum (i.e., Munro microabscesses).
  • A mixed perivascular infiltrate is confined to the papillary dermis.

COMMONLY ASSOCIATED CONDITIONS

  • Obesity
  • Metabolic syndrome
  • Hypertension
  • Depression
  • Anxiety
  • Uveitis
  • Arthritis
  • Rheumatoid arthritis
  • Crohn disease
  • Diabetes mellitus
  • Lymphoma (rare)

There's more to see -- the rest of this topic is available only to subscribers.